ClinicalTrials.gg
CompletedNCT02105298Updated Aug 21, 2015

Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)

An observational study in Respiratory Failure, Acute Respiratory Failure Requiring Reintubation and Pulmonary Edema, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-08-21.

Sponsored by Massachusetts General Hospital · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
104,000
Ages
18 Years and older
Sex
All
01

Study summary

Intraoperative intravenous fluid management practice varies greatly between anesthesiologists. Postoperative fluid based weight gain is associated with major morbidity. Postoperative respiratory complications are associated with increased morbidity, mortality and hospital costs. The literature shows conflicting data regarding intraoperative fluid resuscitation volume. No large-scale studies have focused on intraoperative fluid management and postoperative respiratory dysfunction.

Hypotheses:

Primary - Liberal intraoperative fluid resuscitation is associated with an increased risk of 30 day mortality Secondary - Liberal intraoperative fluid resuscitation is associated with increased likelihood of postoperative respiratory failure, pulmonary edema, reintubation, atelectasis, acute kidney injury and peri-extubation oxygen desaturation.

02

Conditions studied

  • Respiratory Failure
  • Acute Respiratory Failure Requiring Reintubation
  • Pulmonary Edema
  • Pneumonia
  • Hypoxia
  • Acute Kidney Injury

Keywords

  • Fluids
  • Intraoperative
  • Respiratory
  • Outcomes
  • Surgery
  • Anesthesia
03

In context

Respiratory Insufficiency

1,675 studies on the registry are indexed under Respiratory Insufficiency; 300 are open to participants now.

This study's enrollment of 104,000 is above the median of 100 across 556 observational studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,582 studies on the registry; 451 are open to participants now.

Of its 221 completed or terminated interventional studies of FDA-regulated products, 168 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

All surgical patients aged 18 upwards receiving general anesthesia at Massachusetts General Hospital between January 2007 and November 2012

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ages 18 upwards
  • Tracheally intubated at the beginning of the procedure and extubated at the end of the procedure

Exclusion criteria

Exclusion Criteria:

  • Cases where the subject had additional surgeries within the previous four weeks
  • Ages under 18
05

Study design

Time perspective
Prospective
Enrollment
104,000 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Mortality

    Mortality within 30 days of surgery

    Time frame: within 30 days after surgery

Secondary outcomes

  1. Postoperative pulmonary complications

    The incidence of a diagnosis of pneumonia, respiratory failure, atelectasis or pulmonary edema within 3 days after extubation in the operating room. Cases where these diagnoses were present on the day before surgery were not counted.

    Time frame: 3 days after surgery

  2. Acute Kidney Injury

    A Creatinine increase of \>0.3mg/dl or 50% from baseline (Creatinine value closest recorded to surgery but within 30 days of surgery) to maximum value measured within 48 hours postoperatively or an ICD-9 diagnosis of AKI within 7 days of surgery but not within 30 days prior to surgery

    Time frame: within 48 hours of surgery

  3. Post-extubation oxygen desaturation

    One or more minutes with a blood oxygen saturation below 90% during the first ten minutes after extubation

    Time frame: within the first 10 minutes after extubation

07

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02105298
Responsible party
Matthias Eikermann (M.D., Ph.D., Massachusetts General Hospital) — Principal investigator
First posted
Apr 7, 2014
Start date
Sep 2013
Primary completion
Mar 2014
Completion
Mar 2014
Last update
Aug 21, 2015

Study contacts

Matthias J Eikermann, M.D., Ph.D.
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion